Look at efforts using AI and medical imaging to personalize Alzheimer’s treatment by predicting individual therapy responses from existing scans.
Key Takeaways
- NeuroXT and BIDMC expanded a research collaboration to apply AI to Alzheimer’s imaging
- AI models aim to estimate PET-measured Alzheimer’s biomarkers from more accessible MRI scans
- Researchers will analyze patients treated for over a year to evaluate imaging biomarkers’ links to response